ÂÜÀòÂÒÂ×

Rachel Lee, RPh, is a highly experienced professional in drug safety and pharmacovigilance, currently serving as the Manager of Drug Safety and Pharmacovigilance at Dynavax Technologies since May 2020. In this role, Rachel Lee enhances global safety signal detection processes and oversees clinical trial safety activities. Prior positions include Senior Drug Safety Associate and Drug Safety Associate II at Dynavax, where responsibilities involved safety signal detection, report drafting, and regulatory compliance. Rachel Lee's earlier experience as a Pharmacovigilance Specialist at IQVIA involved post-marketing safety surveillance for GSK in multiple Asia Pacific markets. Rachel Lee holds a Professional Certificate in Pharmacoepidemiology from the London School of Hygiene and Tropical Medicine and a BSc (Honours) in Pharmacy from the National University of Singapore.